Replication-competent Herpes Simplex Virus Retargeted to HER2 as Therapy for High-grade Glioma

Oncolytic herpes simplex viruses (HSVs) represent a novel frontier against tumors resistant to standard therapies, like glioblastoma (GBM). The oncolytic HSVs that entered clinical trials so far showed encouraging results; however, they are marred by the fact that they are highly attenuated. We engi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gambini, Eleonora, Reisoli, Elisa, Appolloni, Irene, Gatta, Valentina, Campadelli-Fiume, Gabriella, Menotti, Laura, Malatesta, Paolo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2012
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3345974/
https://ncbi.nlm.nih.gov/pubmed/22354378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.22
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak